Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Short-term Investments (2021 - 2024)

Historic Short-term Investments for Universe Pharmaceuticals (UPC) over the last 4 years, with Q3 2024 value amounting to $1.4 billion.

  • Universe Pharmaceuticals' Short-term Investments rose 10069155.73% to $1.4 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 billion, marking a year-over-year increase of 10069155.73%. This contributed to the annual value of $1.4 billion for FY2024, which is 10069155.73% up from last year.
  • Universe Pharmaceuticals' Short-term Investments amounted to $1.4 billion in Q3 2024, which was up 10069155.73% from $2.5 million recorded in Q1 2024.
  • Universe Pharmaceuticals' 5-year Short-term Investments high stood at $1.4 billion for Q3 2024, and its period low was $1.4 million during Q3 2023.
  • Moreover, its 4-year median value for Short-term Investments was $13.3 million (2023), whereas its average is $205.2 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 8960.31% in 2023, then skyrocketed by 10069155.73% in 2024.
  • Over the past 4 years, Universe Pharmaceuticals' Short-term Investments (Quarter) stood at $13.7 million in 2021, then dropped by 4.2% to $13.1 million in 2022, then tumbled by 89.6% to $1.4 million in 2023, then surged by 100691.56% to $1.4 billion in 2024.
  • Its Short-term Investments stands at $1.4 billion for Q3 2024, versus $2.5 million for Q1 2024 and $1.4 million for Q3 2023.